文献速递妇科

择期非子宫切除腹腔镜良性妇科手术中抗生素预防的双盲随机安慰剂对照试验:一项先导研究

A Double-blinded, Randomized, Placebo-controlled Trial of Antibiotic Prophylaxis in Elective Non-hysterectomy Laparoscopic Surgery for Benign Gynecologic Conditions: A Pilot Study.
PubMed 文献 · J Minim Invasive Gynecol · 2022-05-02

在澳大利亚悉尼大学附属三级转诊医院开展双盲随机安慰剂对照先导试验,评估择期非子宫切除腹腔镜良性妇科手术中抗生素预防术后感染研究的可行性。2019年2月至2021年3月共接触170例患者,招募117例(68.8%),试验药物给药依从率95.7%,随访率99.1%。结论为大规模研究可行,但本先导研究对术后感染率差异检验效能不足,基于本试验感染率估算大规模研究样本量为1678例。

要点

  • 本先导研究招募率为68.8%,试验药物给药依从率95.7%,随访率99.1%。
  • 本先导研究对术后感染率差异检验效能不足,未报告术后感染率数据。
  • 基于本先导研究感染率估算,大规模研究样本量为1678例参与者。

核心结论

  • 本先导研究显示开展大规模研究可行,招募率为接触患者的68%,试验药物给药和随访率均高。
  • 本先导研究对识别术后感染率的临床显著差异检验效能不足。
  • 作者认为开展大规模研究是适当且必要的,以确定抗生素预防的健康相关风险,并强调抗菌药物管理。
  • 基于本先导研究中的感染率,大规模研究的样本量为1678例参与者。

研究设计与样本

  • 双盲、随机、安慰剂对照试验,在澳大利亚悉尼大学附属三级转诊医院开展。
  • 研究对象为年龄大于18岁、因良性妇科疾病接受择期非子宫切除腹腔镜手术的女性。
  • 参与者术前随机接受头孢唑林2 g或安慰剂(10 mL生理盐水),由麻醉医生给药,参与者和研究人员对分组设盲。
  • 主要结局为研究可行性,包括招募率、给药依从率、分娩依从率、双盲维持情况和随访率。
  • 次要结局包括术后感染率、住院时长、再入院、非计划就诊医疗机构和抗生素相关反应。

主要发现

  • 2019年2月至2021年3月期间接触170例患者,招募并随机化117例参与者(68.8%)。
  • 试验药物给药依从率高,为95.7%;随访率高,为99.1%。
  • 本先导研究对术后感染率差异检验效能不足,未报告术后感染率数据。

关键数值与推荐

  • 招募率:接触170例患者中招募117例参与者(68.8%)。
  • 试验药物给药依从率:95.7%。
  • 随访率:99.1%。
  • 基于本先导研究感染率估算,大规模研究样本量为1678例参与者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 如预期,本先导研究对识别术后感染率的临床显著差异检验效能不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: To determine the feasibility of a double-blinded randomized, placebo-controlled study in determining the efficacy of antibiotic prophylaxis in preventing postoperative infections (POIs) in elective nonhysterectomy laparoscopic procedures for benign gynecologic conditions. DESIGN: Double-blinded, randomized, placebo-controlled trial. SETTING: University-affiliated tertiary referral hospital in Sydney, Australia. PATIENTS: Women older than 18 years undergoing elective nonhysterectomy laparoscopic procedures for benign gynecologic conditions were eligible for the study and approached. INTERVENTIONS: Before surgery, participants were randomized to receive either 2-g cephazolin or placebo (10-mL normal saline) administered by the anesthetist. Participants and other research staff were blinded to group allocation. MEASUREMENTS AND MAIN RESULTS: The primary outcome was study feasibility measured by recruitment rates, compliance rates of drug administration, compliance rates of delivery, maintenance of double blinding, and follow-up rates. Secondary outcomes included rate of POIs, length of hospitalization, readmission to hospital, unscheduled presentations to healthcare facilities, and antibiotic-related reactions. Between February 2019 and March 2021, 170 patients were approached with 117 participants (68.8%) recruited and randomized. The study had a high compliance rate of trial drug delivery (95.7%) and a high follow-up rate (99.1%). CONCLUSION: This pilot study has demonstrated feasibility of a large-scale study with a recruitment rate of 68% of patients approached and excellent trial drug delivery and follow-up rates. As anticipated, it is underpowered for identifying clinically significant findings for POI rates. A large-scale study is appropriate and essential to determine the health-related risks of antibiotic prophylaxis with an emphasis on antimicrobial stewardship. The sample size for a large-scale study is 1678 participants based on infection rates in this pilot study.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Lim CY, Alonso A, Koh YY, et al. A Double-blinded, Randomized, Placebo-controlled Trial of Antibiotic Prophylaxis in Elective Non-hysterectomy Laparoscopic Surgery for Benign Gynecologic Conditions: A Pilot Study. J Minim Invasive Gynecol. 2022. PMID: 35513301. doi:10.1016/j.jmig.2022.04.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。